Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haojun Chen

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
Theranostics|July 27, 2017
Quantification of Tumor Vascular Permeability and Blood Volume by Positron Emission TomographyHaojun Chen, Xiao Tong, Lixin Lang, et al.
Molecular Cancer Therapeutics|August 28, 2020
Targeted Radionuclide Therapy in Patient-Derived Xenografts Using <sup>177</sup>Lu-EB-RGDLiang Zhao, Haojun Chen, Zhide Guo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 15, 2021
Positron emission tomography and computed tomography with [<sup>68</sup>Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancerYizhen Pang, Long Zhao, Qihang Shang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 27, 2020
Usefulness of [<sup>68</sup>Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [<sup>18</sup>F]FDG PET/CT findingsHaojun Chen, Liang Zhao, Dan Ruan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 21, 2023
A phase 1 trial to determine the maximum tolerated dose and patient-specific dosimetry of [<sup>177</sup>Lu]Lu-LNC1003 in patients with metastatic castration-resistant prostate cancerJie Zang, Guochang Wang, Tianzhi Zhao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 20, 2025
Assessment of viable tumours by [<sup>68</sup>Ga]Ga-FAPI-04 PET/CT after local regional treatment in patients with hepatocellular carcinomaDongling Zhu, Shuang Song, Sijuan Zou, et al.
Pharmaceutics|September 28, 2023
Dynamic Monitoring of Intracellular Tacrolimus and Mycophenolic Acid Therapy in Renal Transplant Recipients Using Magnetic Bead Extraction Combined with LC-MS/MSHuan Xu, Yingying Liu, Yinan Zhang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 12, 2020
Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [<sup>68</sup>Ga]Ga-FAPI-04 PET/CT versus MRI and [<sup>18</sup>F]-FDG PET/CTWei Guo, Yizhen Pang, Lanlin Yao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 23, 2025
Preclinical and pilot clinical evaluation of novel dual-modality pet/fluorescence probes targeting FAP for accurate tumor margin delineationLiang Zhao, Yizhen Pang, Daqiang Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2023
Fibroblast Activation Protein-Targeted Radioligand Therapy with 177Lu-EB-FAPI for Metastatic Radioiodine-Refractory Thyroid Cancer: First-in-Human, Dose-Escalation StudyHao Fu, Jingxiong Huang, Tianzhi Zhao, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
Theranostics|July 27, 2017
Quantification of Tumor Vascular Permeability and Blood Volume by Positron Emission TomographyHaojun Chen, Xiao Tong, Lixin Lang, et al.
Molecular Cancer Therapeutics|August 28, 2020
Targeted Radionuclide Therapy in Patient-Derived Xenografts Using <sup>177</sup>Lu-EB-RGDLiang Zhao, Haojun Chen, Zhide Guo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 15, 2021
Positron emission tomography and computed tomography with [<sup>68</sup>Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancerYizhen Pang, Long Zhao, Qihang Shang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 27, 2020
Usefulness of [<sup>68</sup>Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [<sup>18</sup>F]FDG PET/CT findingsHaojun Chen, Liang Zhao, Dan Ruan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 21, 2023
A phase 1 trial to determine the maximum tolerated dose and patient-specific dosimetry of [<sup>177</sup>Lu]Lu-LNC1003 in patients with metastatic castration-resistant prostate cancerJie Zang, Guochang Wang, Tianzhi Zhao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 20, 2025
Assessment of viable tumours by [<sup>68</sup>Ga]Ga-FAPI-04 PET/CT after local regional treatment in patients with hepatocellular carcinomaDongling Zhu, Shuang Song, Sijuan Zou, et al.
Pharmaceutics|September 28, 2023
Dynamic Monitoring of Intracellular Tacrolimus and Mycophenolic Acid Therapy in Renal Transplant Recipients Using Magnetic Bead Extraction Combined with LC-MS/MSHuan Xu, Yingying Liu, Yinan Zhang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 12, 2020
Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [<sup>68</sup>Ga]Ga-FAPI-04 PET/CT versus MRI and [<sup>18</sup>F]-FDG PET/CTWei Guo, Yizhen Pang, Lanlin Yao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 23, 2025
Preclinical and pilot clinical evaluation of novel dual-modality pet/fluorescence probes targeting FAP for accurate tumor margin delineationLiang Zhao, Yizhen Pang, Daqiang Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2023
Fibroblast Activation Protein-Targeted Radioligand Therapy with 177Lu-EB-FAPI for Metastatic Radioiodine-Refractory Thyroid Cancer: First-in-Human, Dose-Escalation StudyHao Fu, Jingxiong Huang, Tianzhi Zhao, et al.
Pageof 15